Brief: Jacobson Pharma Corp Sees Increase In Consolidated Profit Attributable For FY
02/05/2019 12:39
May 2 (Reuters) - Jacobson Pharma Corporation Ltd 2633.HK :
* EXPECTED TO RECORD AN INCREASE OF OVER 20% IN CONSOLIDATED
PROFIT ATTRIBUTABLE FOR FY
* EXPECTED INCREASE FY PROFIT DUE TO STEADY GROWTH OF
GROUP'S
GENERIC DRUG BUSINESS
Source text for Eikon: ID:nHKS3YRlzm
Further company coverage: 2633.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobson Pharma
See all newsBrief: Jacobson Pharma Corp Says Chai Herbal To Buy 124,500 Shares Of Li Chung Shing Tong (Holdings)
Brief: Jacobson Pharma Corp's Unit Accepts Tender For Tai Po Factory Works At Hk$607.2 Million
Brief: Jacobson Pharma Corp Posts H1 Revenue Of HKD 766.6 Million
Brief: Jacobson Pharma Corporation Posts FY Net Income Attributable HKD 300.8 Million
Brief: Jacobson Pharma Corporation To Subscribe Shares In Tycoon Group